MJY-79632-63201
4 vaccinations
4 coded responses
39 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 210 / MD
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Moderna
- 2021-01-12
- 2021-01-16
- 2021-01-18
- 2021-01-21
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-12
Dose 2 — Moderna
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-28
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
-
2021-08-13
Survey response — 6 months, dose 2MedDRA: Herpes zoster — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: ShinglesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-19
-
2021-10-28
Dose 3 — Moderna
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · HeadacheFree text: Facial tinglingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-10-31
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-27
- 2021-12-02
- 2021-12-10
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Post partum preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-02-03
-
2022-05-03
Survey response — 6 months, dose 3MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: PreeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-05-04
-
2022-09-18
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-30
- 2022-10-30
- 2022-12-20
- 2023-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
| 4 | 2022-09-18 | Pfizer-BioNTech | Flu |
Call center
3 call center cases
3 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Shingles
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Facial tingling
Release 11 — 3 months, dose 3
Symptoms: Post partum preeclampsia
Release 11 — 6 months, dose 3
Symptoms: Preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eclampsia | · | · | ✓ |
| SD | Herpes zoster | ✓ | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release